These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 6548074)
21. Parathyroid hormone and parathyroid hormone related protein assays in the investigation of hypercalcemic patients in hospital in a Chinese population. Lee JK; Chuang MJ; Lu CC; Hao LJ; Yang CY; Han TM; Lam HC J Endocrinol Invest; 1997; 20(7):404-9. PubMed ID: 9309539 [TBL] [Abstract][Full Text] [Related]
22. How to approach hypercalcaemia. Crowley R; Gittoes N Clin Med (Lond); 2013 Jun; 13(3):287-90. PubMed ID: 23760705 [TBL] [Abstract][Full Text] [Related]
23. Incomplete suppression of parathyroid hormone activity in sarcoidosis presenting with hypercalcaemia. Ghose RR; Woodhead JS; Brown RC Postgrad Med J; 1983 Sep; 59(695):572-4. PubMed ID: 6634558 [TBL] [Abstract][Full Text] [Related]
24. [Circulating metabolites of vitamin D in 14 children with hypercalcemia]. Jacqz E; Garabedian M; Guillozo H; Bourdeau A; Guillot M; Gagnadoux MF; Broyer M; Lenoir G; Balsan S Arch Fr Pediatr; 1985 Mar; 42(3):225-30. PubMed ID: 3873927 [TBL] [Abstract][Full Text] [Related]
25. Differentiation of hypercalcaemia due to malignancy from primary hyperparathyroidism: the value of parathyroid hormone and plasma bicarbonate measurements. Freaney R; Ryan E; Muldowney FP Ir J Med Sci; 1981 Jan; 150(1):6-12. PubMed ID: 7216714 [No Abstract] [Full Text] [Related]
26. Hypercalcaemia of malignancy. Kelly PJ; Eisman JA Cancer Metastasis Rev; 1989 Jun; 8(1):23-52. PubMed ID: 2667784 [TBL] [Abstract][Full Text] [Related]
27. Parathyroid hormone-related peptide, measured by a midmolecule radioimmunoassay, in various hypercalcaemic and normocalcaemic conditions. Bucht E; Eklund A; Toss G; Lewensohn R; Granberg B; Sjöstedt U; Eddeland R; Tørring O Acta Endocrinol (Copenh); 1992 Oct; 127(4):294-300. PubMed ID: 1449040 [TBL] [Abstract][Full Text] [Related]
28. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
29. [Diagnostic significance of parathyroid hormone-related protein in tumor patients with hypercalcemia]. Blind E; Raue F; Meinel T; Pecherstorfer M; Räth U; Schmidt-Gayk H; Kohl B; Ziegler R Dtsch Med Wochenschr; 1993 Mar; 118(10):330-5. PubMed ID: 8453901 [TBL] [Abstract][Full Text] [Related]
30. Direct comparison of sustained infusion of human parathyroid hormone-related protein-(1-36) [hPTHrP-(1-36)] versus hPTH-(1-34) on serum calcium, plasma 1,25-dihydroxyvitamin D concentrations, and fractional calcium excretion in healthy human volunteers. Horwitz MJ; Tedesco MB; Sereika SM; Hollis BW; Garcia-Ocaña A; Stewart AF J Clin Endocrinol Metab; 2003 Apr; 88(4):1603-9. PubMed ID: 12679445 [TBL] [Abstract][Full Text] [Related]
31. Parathyroid hormone related protein and hypercalcaemia in breast cancer. Bundred NJ; Ratcliffe WA; Walker RA; Coley S; Morrison JM; Ratcliffe JG BMJ; 1991 Dec; 303(6816):1506-9. PubMed ID: 1782489 [TBL] [Abstract][Full Text] [Related]
32. Pathogenesis of hypercalcaemia of malignancy. Mundy GR Clin Endocrinol (Oxf); 1985 Dec; 23(6):705-14. PubMed ID: 3006948 [TBL] [Abstract][Full Text] [Related]
33. Familial benign hypercalcaemia. Study of a large family. Menko FH; Bijvoet OL; Fronen JL; Sandler LM; Adami S; O'Riordan JL; Schopman W; Heynen G Q J Med; 1983; 52(206):120-40. PubMed ID: 6310672 [TBL] [Abstract][Full Text] [Related]
34. Associations of serum 25-hydroxyvitamin D with circulating PTH, phosphate and calcium in patients with primary hyperparathyroidism. Jayasena CN; Modi M; Palazzo F; De Silva A; Donaldson M; Meeran K; Dhillo WS Clin Endocrinol (Oxf); 2013 Jun; 78(6):838-43. PubMed ID: 23036072 [TBL] [Abstract][Full Text] [Related]
35. Ratio of parathyroid hormone to 1,25-dihydroxycholecalciferol in early renal failure. Lucas PA; Brown RC; Woodhead JS; Coles GA Kidney Int Suppl; 1983 Dec; 16():S171-4. PubMed ID: 6588249 [No Abstract] [Full Text] [Related]
36. Effects of decreasing serum calcium on circulating parathyroid hormone and vitamin D metabolites in normocalcaemic and hypercalcaemic patients treated with APD. Papapoulos SE; Harinck HI; Bijvoet OL; Gleed JH; Fraher LJ; O'Riordan JL Bone Miner; 1986 Feb; 1(1):69-78. PubMed ID: 3508718 [TBL] [Abstract][Full Text] [Related]
37. Serum parathyroid hormone levels in the hypercalcaemia of urological malignant disease. Ramsay JW; Hendry WF J R Soc Med; 1986 Jun; 79(6):323-5. PubMed ID: 3723531 [TBL] [Abstract][Full Text] [Related]
38. Hypercalcaemia in association with renal failure: the role of immobilisation. Prince RL; Eisman JA; Simpson RW Aust N Z J Med; 1983 Feb; 13(1):8-10. PubMed ID: 6576751 [TBL] [Abstract][Full Text] [Related]
39. Parathyroid hormone (PTH)-related protein, PTH, and 1,25-dihydroxyvitamin D in dogs with cancer-associated hypercalcemia. Rosol TJ; Nagode LA; Couto CG; Hammer AS; Chew DJ; Peterson JL; Ayl RD; Steinmeyer CL; Capen CC Endocrinology; 1992 Sep; 131(3):1157-64. PubMed ID: 1505457 [TBL] [Abstract][Full Text] [Related]
40. Calciotropic hormones and markers of bone remodeling in age-related (type II) femoral neck osteoporosis: alterations consistent with secondary hyperparathyroidism-induced bone resorption. Boonen S; Broos P; Verbeke G; Aerssens J; Van Herck E; Jans I; Dequeker J; Bouillon R J Gerontol A Biol Sci Med Sci; 1997 Sep; 52(5):M286-93. PubMed ID: 9310082 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]